Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.2443
S.2443: Advancing Standards in Regenerative Medicine Act
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Jan. 12, 2016
- Latest Major Action Jan. 12, 2016
Bill Sponsor
Bill Summary
Advancing Standards in Regenerative Medicine Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Jan. 12, 2016 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
Jan. 12, 2016 |
Introduced in the Senate by Tammy Baldwin (D-Wis.) |